Treatment of rheumatism and arteriosclerosis with n-halogenophen

Details Treatment of rheumatism and arteriosclerosis with n-halogenophen Treatment of rheumatism and arteriosclerosis with n-halogenophen

1981-10-22

1983-08-09

Schwartz, Richard A.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

548209, A61K 31425

Patent

active

043978584

ABSTRACT:
The invention relates to the new use of certain benzisothiazoles corresponding to the following general formula: ##STR1## wherein R.sub.1 represents chlorine, fluorine or bromine, and R.sub.2 represents hydrogen, chlorine, fluorine or bromine, in the treatment of phlogistic and/or arteriosclerotic processes.

REFERENCES:
patent: 3012039 (1961-12-01), Morley
patent: 3862955 (1975-01-01), Grivas
Chemical Abstracts, 89:108923e (1978).
Fischer, R., et al., Arzneim.-Forsch., 1964, 14, 1301-1306.
Rufer, C., et al., Eur. J. Med. Chem.-Chim. Ther. 1978, 13(2), 193-198.

Affiliated with

Also associated with

Rating

Treatment of rheumatism and arteriosclerosis with n-halogenophen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of rheumatism and arteriosclerosis with n-halogenophen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of rheumatism and arteriosclerosis with n-halogenophen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-586911